Dominican Republic Healthcare Industry Overview 2026
Understanding the Dominican Republic’s healthcare system provides critical context for medical device manufacturers, pharmaceutical companies, and healthcare investors evaluating the country. The DR’s healthcare market — $3.5–$4.5B in annual spending — is the largest in the non-Hispanic Caribbean and combines a mixed public-private system with growing medical tourism infrastructure and an established medical professional workforce.
Healthcare System Structure
The Dominican Republic’s healthcare system operates under the Sistema Dominicano de Seguridad Social (SDSS), established by Law 87-01. Three financing regimes: (1) Contributory Regime — workers in formal employment with mandatory contributions to Seguro Familiar de Salud (SFS); employer contributes 7.09% and employee 3.04% of salary. (2) Subsidized Regime — population below poverty line covered by government-funded SFS through SISALRIL. (3) Contributory-Subsidized Regime — informal sector workers with partial contributions. Coverage: approximately 70–75% of the population has some form of health insurance under the SDSS as of 2026, up from approximately 35% in 2010. The Ministry of Public Health (MISPAS) oversees the public hospital network; SISALRIL (Superintendencia de Salud y Riesgos Laborales) regulates health insurance providers.
Hospital Infrastructure
The Dominican Republic has approximately 700+ healthcare facilities including public and private hospitals, clinics, and diagnostic centers. Key tertiary referral hospitals: Hospital Dr. Salvador B. Gautier (Santo Domingo, public, cardiology and oncology specialty); Hospital Ney Arias Lora (Santiago, public regional referral); Centro Médico UCE (Santo Domingo, private, established teaching facility); Clínica Abreu (Santo Domingo, private, general surgery); and Clinica Cruz Jiminián (Santo Domingo, private, historically dominant private network). Several US-affiliated and JCI (Joint Commission International) accredited facilities operate in the DR, supporting medical tourism: Hospital General Plaza de la Salud has JCI accreditation; Hospital General de la Plaza de la Salud (HGPS) is the reference oncology and transplant center in the DR.
Medical Device Market Access
For medical device manufacturers, the Dominican Republic’s domestic healthcare market provides a secondary revenue opportunity beyond the primary US export focus. DIGEMAPS registration is required for medical devices sold in the DR domestic market. The DR is part of the Pan American Health Organization (PAHO) network and follows PAHO medical device and pharmaceutical regulatory harmonization initiatives. US-origin medical devices registered with FDA hold a procedural advantage in DIGEMAPS review — FDA clearance provides evidence of safety and efficacy that accelerates DR registration review timelines.
Medical Tourism
The Dominican Republic is an emerging medical tourism destination, primarily for the DR diaspora in the United States (estimated 1.5–2M Dominicans in the US) seeking affordable procedures in familiar cultural and linguistic settings. Cosmetic surgery, dental care, orthopedic procedures, and ophthalmology are the dominant medical tourism categories. Several Santo Domingo clinics market directly to Dominican-Americans in New York and Boston; charter medical packages (procedure + accommodation + recovery) are offered by several private hospital networks. Medical tourism contribution to Dominican healthcare revenue: estimated $100–$200M annually, growing modestly.
Healthcare Workforce
The Dominican Republic produces approximately 3,000–4,000 medical graduates annually from medical schools including UNPHU, UASD (national university), UTESA, and UNIBE — a significant output relative to population that sustains both domestic healthcare delivery and significant physician emigration to the US. Nursing and allied health professional education has been a growth priority; INFOTEP coordinates clinical technical training programs. For medical device manufacturers, this healthcare professional base provides potential end-users for device training programs and a sourcing pool for quality and regulatory affairs professionals with clinical background.
EGS Healthcare Sector Advisory
EGS assists healthcare sector investors and medical device companies with Dominican Republic market assessment, DIGEMAPS registration coordination, and healthcare sector partnership development. Discuss Dominican Republic healthcare sector opportunities with EGS →
Explore More: EGS Insights Hub | DR Manufacturing Sectors | Contact Our Team